Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuo Hamamoto

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
International Journal of Clinical Oncology|August 16, 2018
Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinomaJun Hashimoto, Ken Kato, Yoshinori Ito, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 21, 2015
Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407)Tomohiro Nishina, Narikazu Boku, Masahiro Gotoh, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 26, 2015
Development of an S-1 dosage formula based on renal function by a prospective pharmacokinetic studyEisuke Booka, Chiyo K Imamura, Hiroya Takeuchi, et al.
Japanese Journal of Clinical Oncology|October 23, 2010
Phase III trial of everolimus in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from RECORD-1Taiji Tsukamoto, Nobuo Shinohara, Norihiko Tsuchiya, et al.
Cancer Science|November 6, 2012
Mesenchymal stem cells regulate epithelial-mesenchymal transition and tumor progression of pancreatic cancer cellsAyano Kabashima-Niibe, Hajime Higuchi, Hiromasa Takaishi, et al.
Anticancer Research|September 21, 2012
Colon neoplastic cells do not originate from bone marrow-derived cells after sex-mismatched bone marrow transplantationGen Sakai, Tomoharu Yajima, Hiromasa Takaishi, et al.
BMC Cancer|March 28, 2023
Real-world management and outcomes of older patients with locally advanced esophageal squamous cell carcinoma: a multicenter retrospective studyYuki Saito, Yasuo Hamamoto, Kenro Hirata, et al.
Oncology Letters|July 3, 2018
Pilot study of WT1 peptide-pulsed dendritic cell vaccination with docetaxel in esophageal cancerTatsuo Matsuda, Hiroya Takeuchi, Toshiharu Sakurai, et al.
International Journal of Clinical Oncology|April 19, 2014
Development of hypertension within 2 weeks of initiation of sorafenib for advanced hepatocellular carcinoma is a predictor of efficacyNoriyuki Akutsu, Shigeru Sasaki, Hideyasu Takagi, et al.
Japanese Journal of Clinical Oncology|November 4, 2020
A management of neutropenia using granulocyte colony stimulating factor support for chemotherapy consisted of docetaxel, cisplatin and 5-fluorouracil in patients with oesophageal squamous cell carcinomaChikatoshi Katada, Mitsuhiro Sugawara, Hiroki Hara, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
International Journal of Clinical Oncology|August 16, 2018
Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinomaJun Hashimoto, Ken Kato, Yoshinori Ito, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 21, 2015
Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407)Tomohiro Nishina, Narikazu Boku, Masahiro Gotoh, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 26, 2015
Development of an S-1 dosage formula based on renal function by a prospective pharmacokinetic studyEisuke Booka, Chiyo K Imamura, Hiroya Takeuchi, et al.
Japanese Journal of Clinical Oncology|October 23, 2010
Phase III trial of everolimus in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from RECORD-1Taiji Tsukamoto, Nobuo Shinohara, Norihiko Tsuchiya, et al.
Cancer Science|November 6, 2012
Mesenchymal stem cells regulate epithelial-mesenchymal transition and tumor progression of pancreatic cancer cellsAyano Kabashima-Niibe, Hajime Higuchi, Hiromasa Takaishi, et al.
Anticancer Research|September 21, 2012
Colon neoplastic cells do not originate from bone marrow-derived cells after sex-mismatched bone marrow transplantationGen Sakai, Tomoharu Yajima, Hiromasa Takaishi, et al.
BMC Cancer|March 28, 2023
Real-world management and outcomes of older patients with locally advanced esophageal squamous cell carcinoma: a multicenter retrospective studyYuki Saito, Yasuo Hamamoto, Kenro Hirata, et al.
Oncology Letters|July 3, 2018
Pilot study of WT1 peptide-pulsed dendritic cell vaccination with docetaxel in esophageal cancerTatsuo Matsuda, Hiroya Takeuchi, Toshiharu Sakurai, et al.
International Journal of Clinical Oncology|April 19, 2014
Development of hypertension within 2 weeks of initiation of sorafenib for advanced hepatocellular carcinoma is a predictor of efficacyNoriyuki Akutsu, Shigeru Sasaki, Hideyasu Takagi, et al.
Japanese Journal of Clinical Oncology|November 4, 2020
A management of neutropenia using granulocyte colony stimulating factor support for chemotherapy consisted of docetaxel, cisplatin and 5-fluorouracil in patients with oesophageal squamous cell carcinomaChikatoshi Katada, Mitsuhiro Sugawara, Hiroki Hara, et al.
Pageof 13